ATIM-12. AVELUMAB IN NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME-THE SEJ STUDY

INTRODUCTION: Glioblastoma Multiforme (GBM) has well documented systemic and local immunosuppressive mechanisms to escape immune surveillance. GBM tumor cells as well as the microglia within it have a high PD-L1 surface expression which may make it susceptible to anti-PD-L1 antagonism and ADCC with...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Neuro Oncol
Hoofdauteurs: Jacques, Francois, Nicholas, Garth, Lorimer, Ian, Sikatifoko, Victorine, Dumais, Nathalie
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2019
Onderwerpen:
Adult Clinical Trials–Immunologic
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847894/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.012
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items